Coagulation and platelet activation after retinal vein occlusions

Area of Science:

• Ophthalmology
• Hematology
• Vascular Biology

Background:

• Retinal vein occlusions (RVO) can affect individuals of all ages.
• The role of thrombotic factors in young RVO patients is not fully understood.
• Identifying underlying causes is crucial for effective management and prevention.

Purpose of the Study:

• To investigate the involvement of coagulation and platelet activation in young patients with RVO.
• To assess specific biomarkers related to thrombosis in this patient group.

Main Methods:

• Measured beta-thromboglobulin (B-TG), circulating platelet aggregates (CPA), thromboxane B2 (TxB2), and fibrinopeptide A (FPA).
• Studied 25 patients under 40 years old diagnosed with RVO, post-acute phase.
• Compared patient levels to those of healthy subjects.

Main Results:

• Fibrinopeptide A (FPA) and beta-thromboglobulin (B-TG) levels were significantly elevated in RVO patients compared to controls.
• Circulating platelet aggregates (CPA) and thromboxane B2 (TxB2) levels did not differ significantly between groups.
• Elevated FPA and B-TG suggest increased coagulation and platelet activation.

Conclusions:

• A thrombophilic state, marked by coagulation and platelet activation, is prevalent in young RVO patients without generalized vascular disease.
• These findings highlight potential prothrombotic mechanisms contributing to RVO in younger individuals.
• Further research into thrombophilia screening for young RVO patients is warranted.